Shanghai Nianxing Industrial Co., Ltd
China
Product Name: IRG1-IN-1
Price: Check
Purity: 99.36%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

2407652-42-8

2407652-42-8 structure

2407652-42-8 structure

Name: IRG1-IN-1
Chemical Name: IRG1-IN-1
CAS Number: 2407652-42-8
Molecular Formula: C₁₈H₁₅FO₄
Molecular Weight: 314.31
Catalog: Research Areas Cancer
Create Date: 2022-12-11 15:03:44
Modify Date: 2025-08-25 18:50:47
IRG1-IN-1 is an itaconic acid derivative. IRG1-IN-1 can inhibit immune-responsive gene 1 (IRG1) activity. IRG1-IN-1 can be used for the research of cancer, inflammation and autoimmune diseases[1].

Name	IRG1-IN-1

Description	IRG1-IN-1 is an itaconic acid derivative. IRG1-IN-1 can inhibit immune-responsive gene 1 (IRG1) activity. IRG1-IN-1 can be used for the research of cancer, inflammation and autoimmune diseases[1].
Related Catalog	Research Areas >> Cancer Research Areas >> Infection Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
In Vitro	IRG1-IN-1(compound 6) (0.5 mM; 2 mM) reduces production of itaconic acid and the secretion of TNFα from LPS-stimulated human monocyte derived macrophages (hMDMs) [1]. IRG1-IN-1 (0.5 mM; 1 mM) inhibits the proliferation of C-IRG1-9 rat glioma cells[1]. IRG1-IN-1(10 nM) increases proliferation of TCR-activated hCD8+ T cells[1]. IRG1-IN-1(10μM) shows depletion of trimethylation of histone 3 at lysine 4 (H3K4me3) in CR-activated hCD8+ T cells[1]. Western Blot Analysis[1] Cell Line: TCR-activated hCD8+ T cells Concentration: 10 μM Incubation Time: 24-72 h Result: Decreased protein levels of histone 3 (H3). Cell Proliferation Assay[1] Cell Line: C-IRG1-9 rat glioma cells and TCR-activated hCD8+ T cells Concentration: 0.5 mM; 1 mM; 10 nM Incubation Time: 48-96 h Result: Inhibited the proliferation of C-IRG1-9 rat glioma cells and increased proliferation of TCR-activated hCD8+ T cells.
In Vivo	IRG1-IN-1 (compound 6) (i.p.; 0.2 mg/kg; 27 days) shows antitumor effect in C57BL/6 mice[1]. Animal Model: C57BL/6 mice[1] Dosage: 0.2 mg/kg Administration: IP; 27 days Result: Increased survival of C57BL/6 mice bearing mouse CT26 colorectal tumors. Decreased intratumoral frequency of M-MDSCs in tumors.
References	[1]. Adonia Papathanassiu, et al. Compositions and methods of using itaconic acid derivatives. Patent. US20210261495A1.

Molecular Formula	C₁₈H₁₅FO₄
Molecular Weight	314.31

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.